Publication | Closed Access
Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan
17
Citations
27
References
2021
Year
Bone DiseaseRomosozumab Versus TeriparatideOsteopathySevere Postmenopausal OsteoporosisOrthopaedicsCost EffectivenessMedicineOsteoporosisOrthopaedic Surgery
| Year | Citations | |
|---|---|---|
Page 1
Page 1